The first outpatient trial of an artificial pancreas has been launched by the University of Virginia. The researchers say that the artificial pancreas, which uses a reconfigured smartphone to monitor an insulin pump and a continuous glucose monitor, will help make diabetes easier to manage by automating a lot of the testing that is involved in diabetes.
It is hoped that using this method will help keep make glucose levels easily to control and works to automate the constant glucose monitoring that diabetics need to do to ensure that their insulin levels are correct and that their blood sugars are at a healthy level.
The device has been tested by Charlottesville resident Justin Wood, who has been diabetic for twenty eight years. Commenting on the two day trial, Wood said:
“The operating interface was very slick and very fast."
“The extra second or two you save pressing buttons adds up when you have to do it every day.”
He went on to say:
“The device automates a lot of the tracking and monitoring I do now."
Wood says that the new monitoring system meant that he could reduce the amount of blood tests that he has to do every day to just two instead of the three - five tests that he would usually do.
The team behind the artificial pancreas, as it is being described is led by Patrick Keith-Hynes, PhD, and Boris Kovatchev. Outpatients tests will continue between now and into 2013 and a further 120 patients will be enrolled into the programme.
It is hoped that using this method will help keep make glucose levels easily to control and works to automate the constant glucose monitoring that diabetics need to do to ensure that their insulin levels are correct and that their blood sugars are at a healthy level.
The device has been tested by Charlottesville resident Justin Wood, who has been diabetic for twenty eight years. Commenting on the two day trial, Wood said:
“The operating interface was very slick and very fast."
“The extra second or two you save pressing buttons adds up when you have to do it every day.”
He went on to say:
“The device automates a lot of the tracking and monitoring I do now."
Wood says that the new monitoring system meant that he could reduce the amount of blood tests that he has to do every day to just two instead of the three - five tests that he would usually do.
The team behind the artificial pancreas, as it is being described is led by Patrick Keith-Hynes, PhD, and Boris Kovatchev. Outpatients tests will continue between now and into 2013 and a further 120 patients will be enrolled into the programme.
No comments:
Post a Comment